Home Search

drug development - search results

If you're not happy with the results, please do another search
agricultural research

Advancing food and agricultural research in the U.S

The USDA’s Agricultural Research Services and National Institute of Food & Agriculture both play key roles in advancing food and agricultural research, effective resource management and economic opportunities for rural communities, as Open Access Government learns
Neurodegenerative disorders

Neurodegenerative disorders in the U.S.

The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
health and social care

The priorities for health and social care policy in Germany

The priorities for health and social care policy in Germany are placed under the spotlight here by Open Access Government, including the Federal Minister of Health’s ambitions for the elderly care sector.
didgital innovation

Digital innovation in diabetes: From health promotion to integrated care provision

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
Infectious Disease

Antimicrobial resistance (AMR) at the Southern Africa Centre for Infectious Disease Surveillance

Mecky Isaac Matee, Leader of the SACIDS AMR CoP profiles the excellent antimicrobial resistance (AMR) research taking place at the Southern Africa Centre for Infectious Disease Surveillance (SACIDS).
paediatric imaging

Non-radioactive, non-ionising radiation for safe paediatric imaging

E.M. Sevick and J.C. Rasmussen from The University of Texas Health Science Center, The Brown Foundation Institute of Molecular Medicine discuss non-radioactive, non-ionising radiation for safe, paediatric imaging
acute myeloid leukaemia

CD33-directed therapy: Current and future perspectives on targeted therapy in acute myeloid leukaemia (AML)

Mohammed Gbadamosi and Jatinder K Lamba from Department of Pharmacotherapy and Translational Research at the University of Florida explain CD33-directed therapy for acute myeloid leukaemia (AML), focussing on current and future perspectives

Rebuilding tissues inside the human body

Scientific progress to grow new tissues outside of the human body led to first market approvals of living tissue-engineered implants The creation of living tissues to replace or repair damaged tissues or organs in the human body has defied clinicians and researchers for centuries. Yet, only by the end of...
Huntington's Disease

New research suggests Huntington’s Disease may take affect sooner than expected

The National Academy of Sciences (PNAS) has published new research which reveals that Huntington's Disease may take affect in people much earlier on in life than originally expected and that a new drug may be paramount in controlling the disease.
mobile health

Mobile health monitoring systems that address diabetes

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares her thoughts on mobile health monitoring systems that address the global concern of diabetes
therapeutic intervention

What’s in an aggregate? Therapeutic intervention in Huntington’s

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
chronic inflammatory lung diseases

The need to improve the diagnosis of chronic inflammatory lung diseases

Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
molecular signalling

TGF-β signalling – Tumor biology in prostate cancer

Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis
medicine

From molecule to medicine

A report this week from the Office of Health Economics (OHE) shows the amazing impact medicines have had on the NHS and more widely
synergy

Cutting-edge technology synergy in the personalised nanomedicine space: Focus on 3D printing nanomedicines

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision synergy Group explains the role of cutting-edge technology in the personalised nanomedicine space, with a special focus on 3D printing nanomedicines.
heterocyclic

Heterocyclic chemistry: Not just what you do but how you think about it

Heterocyclic chemistry is linked to a number of scientific discoveries and breakthroughs, both directly and indirectly. Professor Colin Suckling of the University of Strathclyde discusses the links and the thinking behind it.
infectious diseases

The World Health Organization: Tackling infectious diseases in Africa

Open Access Government explores the work of the World Health Organization (WHO) Regional Office for Africa in tackling infectious diseases, including tuberculosis (TB)
infectious diseases in africa

The detection, identification and monitoring of infectious diseases in Africa

The Southern African Centre for Infectious Disease Surveillance detail the issues around the detection, identification and monitoring of infectious diseases in Africa today
Anti-microbial resistance

Fighting antimicrobial resistance: Exploring new tools to beat bad bugs

Based on fundamental research, young scientists at the IBPC explore new approaches to fight against the global threat of antimicrobial resistance, according to two seasoned experts from Institut de Biologie Physico-Chimique – CNRS
compliance

Compliance: Reassurance in today’s complex and fast- changing world

Stuart Woolgar, CEO of Global Guardians Management Ltd explains why compliance is a reassurance in today’s complex and fast-changing world

Follow Us

Advertisements